ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Publisher Receives Six Figures Settlement In Copyright Case

May 11, 1990

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

NCI to Fund research In Tobacco Use Prevention In Youth

December 6, 1996

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

New Drug Combination Shrinks Kidney Cancers

June 30, 2006

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980